Quince Therapeutics, Inc.

Q4 2021 vs. Q1 2022 13F Holders

Period
Q4 2021
Q1 2022
Num holders
133
104
Total reported value, excl. options
$249 M
$99.5 M
Total shares, excl. options
19,749,817
16,924,081
Manager Q4 2021
Shares 		Q1 2022
Shares 		Diff Chg %